Serbia's genome center monitors potential virus mutations to facilitate more effective COVID-19 control
In partnership with BGI Genomics from China, Serbia's first genome sequencing center, opened in December 2021, is monitoring potential virus mutations to facilitate more effective COVID-19 control and accelerating access to genomics to enhance health outcomes.
Source: news-medical.net
